Intellectual Property

  • April 09, 2026

    Welch's Maker Tells ITC Rival Infringing 2 Fruit Snack Patents

    The manufacturer of Welch's Fruit Snacks brought its fight against what it claims are patent-infringing yogurt-covered snacks produced by rival Cibo Vita to the U.S. International Trade Commission, the ITC said Thursday.

  • April 09, 2026

    Doctor Who Sued Biotech Co. Over Arrest Wins $58M Verdict

    A Georgia jury has handed a $58 million verdict to a retired Stanford University medical school professor who accused a Peach State biotech firm of conspiring to​​ have him criminally charged in a failed bid to avoid paying him millions in product design commissions.

  • April 09, 2026

    Ex-Joe Gibbs Racing Director Pans 'Desperate' Discovery Bid

    Joe Gibbs Racing LLC's efforts to subpoena cellphone providers for deleted text messages is a "desperate" ploy to dig up proof its trade secrets were stolen when there is no evidence to suggest that is the case, the NASCAR team's former competition director said.

  • April 09, 2026

    Investor Says Chinese Firms Took $476M EV Venture Stake

    A British Virgin Islands company accused a Chinese state-owned enterprise of exploiting COVID-19 travel bans to seize its 11% stake in an electric vehicle manufacturer, wiping out the investor's equity without compensation and stealing proprietary technology.

  • April 09, 2026

    Church Wins Default Judgment Against Proud Boys In TM Suit

    A Washington, D.C., African Methodist Episcopal church has won a default judgment and permanent injunction against a New York chapter of the extremist Proud Boys group barring the chapter from further infringement of the church's "Proud Boys" mark.

  • April 09, 2026

    Nonprofit Insurer Wants To Seek AstraZeneca Claims Revival

    EmblemHealth asked a Massachusetts federal judge to let it seek First Circuit intervention against a decision that cut in half its proposed class action accusing AstraZeneca unit Alexion of using sham patents to protect blood disorder treatment Soliris from biosimilar rivals.

  • April 09, 2026

    Albright Clears Computer Cooling Systems Co. In Patent Fight

    Green Revolution Cooling Inc. was handed a quick win by U.S. District Judge Alan Albright in a suit accusing it of infringing a competitor's patent on products used to cool down electronics at data centers, just before a trial was set to start next month.

  • April 09, 2026

    Abiomed Can't Escape Blood Pump Patent Case

    A Massachusetts federal judge has refused to let a Johnson & Johnson MedTech subsidiary dodge claims that it infringed a blood pump patent, the latest event in a wider legal battle launched against it by a unit of Swedish medical device company Getinge AB.

  • April 09, 2026

    Ex-Pharmacy Director Denies Using Trade Secrets At New Job

    A former director at a specialty infusion therapy pharmacy urged a New Jersey federal court to reject her former employer's bid to block her from working for a rival, arguing that her new job does not pose any threat of imminent harm to her former company.

  • April 09, 2026

    Copyright Chief Decries 'Cataclysmic' High Court Cox Ruling

    U.S. Copyright Office leader Shira Perlmutter expressed grave concern at a conference Thursday about the ramifications of the U.S. Supreme Court's recent decision shielding Cox Communications in a music piracy case, saying the "somewhat cataclysmic" ruling significantly restricted copyright infringement liability.

  • April 09, 2026

    ITC Opens Investigation Into Imported Screen Protectors

    The U.S. International Trade Commission on Thursday said it is opening an investigation into Belkin's claims that a rival is importing and selling screen protectors that infringe a trio of Belkin patents.

  • April 09, 2026

    PNC Tells Justices $233M Patent Win Was Rightly Axed

    PNC Bank told the U.S. Supreme Court to leave untouched a Federal Circuit ruling that nixed a set of $233 million patent infringement verdicts in suits brought by the United Services Automobile Association, saying USAA's patents were "plainly directed to an abstract idea" not eligible for patent protection.

  • April 09, 2026

    Heim Payne Adds New TM Litigation & Appeals Group Leader

    Houston-based Intellectual property boutique Heim Payne & Chorush LLP has brought on an attorney with decades of experience, including time as an examiner with the U.S. Patent and Trademark Office early in her legal career, to lead the firm's trademark litigation and appeals practice.

  • April 09, 2026

    Ex-Assurant Workers Look To Toss RICO, Trade Secrets Suit

    A group of former Assurant salesmen called the auto warranty underwriter's eighth attempt at bringing Racketeer Influenced and Corrupt Organizations and trade secrets claims a shotgun pleading, arguing in Georgia federal court that competition and criminal enterprise are not the same.

  • April 08, 2026

    Fed. Circ. Questions Specificity Needed In Oxy IP Invalidation

    A Federal Circuit panel expressed frustration with attorneys from both Purdue Pharma LP and generic-drug maker Accord Healthcare Inc. Wednesday as it tried to navigate whether the Delaware district court order invalidating Purdue's abuse-deterrence patent was explicit enough.

  • April 08, 2026

    Erotic Influencer's Pot Co. Sued For Infringing Lil Baby's IP

    An erotic content influencer, her entrepreneur boyfriend and their Miami-based cannabis company are accused of tarnishing rapper Lil Baby's brand and trademarks by using them to push contaminated marijuana products while tying them to "explicit" adult content, according to a California federal lawsuit.

  • April 08, 2026

    Vegas Performer Wants To Block Taylor Swift's 'Showgirl' Use

    A Las Vegas performer who has accused Taylor Swift of infringing her long-held "Confessions of a Showgirl" trademark asked a California federal judge to block the pop powerhouse from using "The Life of a Showgirl" on merchandise and for performances while the suit plays out in court.

  • April 08, 2026

    New Patent Owner Filings Expected To Drive Down Reexams

    A new U.S. Patent and Trademark Office procedure allowing patent owners to respond to ex parte reexamination requests has the potential to shake up the process and lead to fewer reexams being instituted since the office can now hear from both sides, attorneys say.

  • April 08, 2026

    Starbucks Ends Wash. 'Patent Troll' Suit Against 2 Irish Cos.

    Starbucks Corp. agreed to drop its lawsuit against two Irish companies the coffee giant had accused of breaking a Washington law against "bad faith" patent infringement claims, according to a joint motion Tuesday asking a Washington federal judge to dismiss the action.

  • April 08, 2026

    Samsung Wants New Trial After $78.5M Patent Verdict

    Samsung is seeking a new trial after an Eastern District of Texas jury said it owed $78.5 million for infringing patents covering automatic content recognition technology for commercial advertising, calling the first trial "fundamentally unfair."

  • April 08, 2026

    Fed. Circ. Zeroes In On Ecobee Jury Instruction Beef

    Judges on the Federal Circuit suggested that a lower court's jury form and instructions could undo at least some of an $11.5 million award against ecobee Technologies in a smart thermostat infringement row with Ollnova Technologies, particularly in light of the Federal Circuit's 2025 decision in a fight between Optis and Apple.

  • April 08, 2026

    OpenAI Witness Was Unprepared In IP MDL Depo, Judge Finds

    A New York federal judge has given news organizations and authors additional time to depose an OpenAI employee in litigation accusing the artificial intelligence company of using copyrighted material to train ChatGPT, saying the employee's lack of preparation and OpenAI counsel's "pattern of repeated objections" impeded his earlier deposition.

  • April 08, 2026

    Military Gear Co. Says Ex-Director Stole Trade Secrets

    A manufacturer of military protective equipment accused a former director in Virginia federal court Tuesday of stealing sensitive information with the intent to use it to gain an unfair advantage in his next venture.

  • April 08, 2026

    Optis Wants 4th Trial On 4G Patents Against Apple

    Optis Wireless Technologies asked a Texas federal judge for a favorable judgment or a new trial Wednesday after a jury cleared Apple of patent infringement allegations in the case's third trial in February.

  • April 08, 2026

    DOJ Backs Patent Rights In Samsung Case Against Netlist

    The U.S. Department of Justice told a Delaware federal court that having a patent included in a standard does not necessarily give the patentholder market power, while weighing in on Samsung's case accusing Netlist of exploiting the standard-setting process.

Expert Analysis

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Checking In On Biologics-Related Patent Review Trends

    Author Photo

    Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Patent Eligibility Faces Widening Gap Between USPTO, Courts

    Author Photo

    The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.

  • Series

    Playing Tennis Makes Me A Better Lawyer

    Author Photo

    An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.

  • Expect Major Shifts In Patent And Trademark Policy This Year

    Author Photo

    New leadership and initiatives promise to bring consequential changes to the U.S. Patent and Trademark Office's practices in 2026, likely favoring patent allowance and issuance, as well as streamlining trademark processes, say attorneys at Knobbe Martens.

  • And Now A Word From The Panel: MDL Year In Review

    Author Photo

    2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.

  • Series

    Judges On AI: How Judicial Use Informs Guardrails

    Author Photo

    U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.

  • Evenflo IP Ruling Shows Evidence Is Still Key For Injunctions

    Author Photo

    Notwithstanding renewed policy and doctrinal attention to patent injunctions, the Federal Circuit's December decision in Wonderland v. Evenflo signals that the era of easily obtained patent injunctions has not yet arrived, say attorneys at King & Wood.

  • What US Cos. Must Know To Comply With Italy's AI Law

    Author Photo

    Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.

  • Navigating Battery Validation Risk In The EV Supply Chain

    Author Photo

    Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe — and for legal teams, battery validation is now a driver of contractual disputes, regulatory exposure and even shareholder litigation, say Samuel Madden at Secretariat Advisors and Vanessa Miller at Foley & Lardner.

  • Fed. Circ. In 2025: A Look At Continued USPTO Tensions

    Author Photo

    Unanticipated developments in 2025 included a tug-of-war between the Federal Circuit and the U.S. Patent and Trademark Office over inter partes review decisions, and this continued disparity looks set to contribute to another packed year for the court, say attorneys at Knobbe Martens.

  • How 2025 Recalibrated Fair Use For The AI Era

    Author Photo

    Although the Second Circuit's decision last year in Romanova v. Amilus Inc. did not involve artificial intelligence, its formulation of relevant fair use factors provides a useful guide for lower courts examining AI cases in 2026, demanding close attention from legal practitioners on both sides of these disputes, say attorneys at Cleary.

  • Series

    Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief

    Author Photo

    My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.

  • Patent Applicants Must Get Biologics Enablement Right

    Author Photo

    As artificial intelligence increasingly becomes a core driver in drug discovery, it is critical for drug companies to adapt their drafting strategies to the unique features of AI-generated inventions, and to pay particularly close attention to enablement standards, says Sanandan Malhotra at Novo Nordisk.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.